tiprankstipranks
Trending News
More News >
Chugai Pharmaceutical Co Ltd (JP:4519)
:4519
Japanese Market

Chugai Pharmaceutical Co (4519) Financial Statements

Compare
4 Followers

Chugai Pharmaceutical Co Financial Overview

Chugai Pharmaceutical Co's market cap is currently ¥14.02T. The company's EPS TTM is ¥76.31; its P/E ratio is 35.34; and it has a dividend yield of 1.17%. Chugai Pharmaceutical Co is scheduled to report earnings on October 24, 2025, and the estimated EPS forecast is ¥75.67. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 1.17T¥ 1.11T¥ 1.26T¥ 999.76B¥ 786.95B
Gross Profit¥ 830.75B¥ 693.01B¥ 783.06B¥ 660.27B¥ 511.77B
Operating Income¥ 543.91B¥ 415.67B¥ 533.94B¥ 433.74B¥ 306.88B
EBITDA¥ 574.80B¥ 475.64B¥ 562.66B¥ 450.30B¥ 328.72B
Net Income¥ 387.32B¥ 325.47B¥ 374.43B¥ 303.00B¥ 214.73B
Balance Sheet
Cash & Short-Term Investments¥ 996.35B¥ 738.98B¥ 503.11B¥ 471.97B¥ 378.62B
Total Assets¥ 2.21T¥ 1.93T¥ 1.87T¥ 1.54T¥ 1.24T
Total Debt¥ 10.90B¥ 13.46B¥ 14.11B¥ 16.04B¥ 11.28B
Net Debt¥ -529.30B¥ -445.22B¥ -208.06B¥ -251.71B¥ -201.05B
Total Liabilities¥ 306.87B¥ 306.97B¥ 445.37B¥ 350.68B¥ 255.50B
Stockholders' Equity¥ 1.90T¥ 1.63T¥ 1.42T¥ 1.19T¥ 980.00B
Cash Flow
Free Cash Flow¥ 396.68B¥ 335.67B¥ 172.87B¥ 206.76B¥ 143.62B
Operating Cash Flow¥ 447.60B¥ 409.93B¥ 244.11B¥ 279.63B¥ 205.03B
Investing Cash Flow¥ -227.37B¥ -37.29B¥ -145.99B¥ -118.93B¥ -98.31B
Financing Cash Flow¥ -141.01B¥ -139.33B¥ -145.64B¥ -107.41B¥ -99.50B
Currency in JPY

Chugai Pharmaceutical Co Earnings and Revenue History

Chugai Pharmaceutical Co Debt to Assets

Chugai Pharmaceutical Co Cash Flow

Chugai Pharmaceutical Co Forecast EPS vs Actual EPS